HYGN yields 2000000.00% · JNJ yields 2.13%● Live data
📍 HYGN pulled ahead of the other in Year 1
Combined, HYGN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HYGN + JNJ for your $10,000?
Hydrogenetics, Inc., through its subsidiary, HydroAxis Technologies, Inc., develops a hydrogen generating system to be used as a complete device for gas and diesel internal combustion engine in various markets worldwide, such as automotive, truck, marine, farm tractors, earth moving vehicles, military, locomotive engines, mining, home heating units, generators, recreation vehicles, fork trucks, and lawn mowers using diesel or gas engines. It also owns Pacific Lights Entertainment, Inc., a film production company that produces small budget films in the comedy and Sci-Fi genres. The company, through its other subsidiary, Buffalo Biodiesel Inc., collects and sources waste vegetable oil from commercial food preparation establishments, and reselling it as raw feedstock to bio-diesel refineries; and sells bio-diesel and yellow grease for the production of bio-diesel to companies in the United States and internationally. The company was formerly known as Global Entertainment Acquisition Corp. and changed its name to Hydrogenetics, Inc. in August 2008. The company was incorporated in 1996 and is based in Fort Lauderdale, Florida.
Full HYGN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.